Gujarat Kidney & Super Speciality
Gujarat Kidney & Super Speciality (GKSL) share price was ₹171.50 at the 28 Oct 2026 close; market capitalisation ₹1,352 Cr; P/E (TTM) 80.14; sector Healthcare Services. In the Jun 2026 quarter, revenue rose 124.7% year on year to ₹34.29 Cr and net profit was ₹5.32 Cr, against ₹5.40 Cr a year earlier (compared with Jun 2025). Promoters held 71.45% of Gujarat Kidney & Super Speciality in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 51/100 (Average) as of 28 Oct 2026.
Key Fundamentals
MicrocapHospitalsHealthcare ServicesPrice-based figures as of 28 Oct 2026, 15:51 IST · EPS basis: Consolidated · TTM
Peer Comparison
Healthcare › Healthcare Services › Hospitals › Hospital
| ₹8,137.00 | 55.99 | 1,16,998 Cr | 12.34 | 0.26% | 20.08% | 19.79% | 26,675 Cr | 2,171 Cr | |
| ₹643.25 | 85.77 | 84,612 Cr | 5.15 | 0.00% | 10.42% | 9.50% | 11,400 Cr | 906 Cr | |
| ₹851.50 | 56.84 | 82,877 Cr | 7.71 | 0.24% | 13.42% | 12.70% | 8,879 Cr | 1,457 Cr | |
| ₹669.45 | 108.85 | 58,354 Cr | 13.87 | 0.45% | 8.84% | 9.71% | 5,006 Cr | 363 Cr | |
| ₹759.50 | 54.72 | 57,339 Cr | 5.79 | 0.14% | 10.47% | 12.13% | 9,607 Cr | 1,070 Cr | |
| ₹1,723.10 | 43.14 | 35,213 Cr | 7.76 | 0.26% | 17.85% | 11.39% | 9,185 Cr | 816 Cr | |
| ₹1,283.00 | 62.01 | 34,496 Cr | 8.71 | 0.04% | 13.91% | 15.05% | 4,800 Cr | 552 Cr | |
| Gujarat Kidney & Super Speciality (this company) | ₹171.50 | 80.14 | 1,352 Cr | 5.35 | 0.00% | 6.60% | 8.57% | 103 Cr | 17 Cr |
| Median 8 companies | ₹805.50 | 59.43 | 57,847 Cr | 7.73 | 0.19% | 11.95% | 11.76% | 9,032 Cr | 861 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
v2.0.0
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 172 days.
- Working capital days have increased from 55.7 days to 91.1 days
Technical Indicators
Oscillators
Bullish
Overall
Neutral
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 24.41% · Jun 2026
Quarterly Results
| Particulars | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 9.41 | 11.79 | 9.78 | 15.26 | 12.93 | 23.25 | 30.58 | 34.29 |
| Expenses | 4.55 | 7.19 | 7.17 | 6.64 | 7.81 | 16.35 | 24.28 | 25.92 |
| Operating Profit | 4.86 | 4.6 | 2.61 | 8.62 | 5.12 | 6.9 | 6.3 | 8.37 |
| OPM % | 51.65% | 39.02% | 26.69% | 56.49% | 39.6% | 29.68% | 20.6% | 24.41% |
| Other Income | 0.04 | 0.05 | 0.05 | 0.01 | 0.09 | 0.06 | 0.71 | 0.69 |
| Interest | 0.16 | 0.17 | 0.16 | 0.18 | 0.28 | 0.6 | 0.82 | 0.66 |
| Depreciation | 0.74 | 0.88 | 0.9 | 0.96 | 0.9 | 1.33 | 1.51 | 1.44 |
| PBT | 4 | 3.6 | 1.6 | 7.49 | 4.03 | 5.03 | 4.68 | 6.96 |
| Tax % | 26.25% | 29.72% | 16.88% | 27.77% | 28.54% | 26.44% | -2.99% | 23.56% |
| Net Profit | 2.96 | 2.53 | 1.34 | 5.4 | 2.88 | 3.7 | 4.82 | 5.32 |
| EPS (₹) | 18.39 | 15.53 | 0.23 | 0.85 | 0.47 | 0.37 | 0.64 | 0.66 |
Profit & Loss
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|
| Sales | 0 | 5 | 40 | 82 | 101 |
| Expenses | 0 | 3 | 24 | 55 | 74 |
| Operating Profit | 0 | 2 | 17 | 27 | 27 |
| OPM % | — | 41% | 41% | 33% | 26% |
| Other Income | 0 | 1 | 0 | 1 | 2 |
| Interest | 0 | 0 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 3 | 5 | 5 |
| PBT | 0 | 2 | 13 | 21 | 21 |
| Tax % | 0% | 25% | 26% | 21% | — |
| Net Profit | 0 | 2 | 10 | 17 | 17 |
| EPS (₹) | -0.5 | 85.5 | 1.66 | 1.97 | 2.14 |
| Div. Payout % | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 0.2 | 0.2 | 11 | 16 |
| Reserves | 0 | 11 | 15 | 237 |
| Borrowings | 0 | 6 | 8 | 29 |
| Other Liabilities | 4 | 4 | 21 | 16 |
| Total Liabilities | 4 | 21 | 55 | 298 |
| Fixed Assets | 0 | 14 | 31 | 129 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 12 |
| Other Assets | 4 | 7 | 24 | 157 |
| Total Assets | 4 | 21 | 55 | 298 |
Cash Flow
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | 0 | 1 | 14 | -4 |
| Investing | 0 | 0 | -18 | -214 |
| Financing | 0 | 0 | 6 | 228 |
| Net Cash Flow | 0 | 1 | 2 | 11 |
| Free Cash Flow | 0 | 2 | -5 | -98 |
| CFO/OP | 0 | 70 | 99 | 21 |
Ratios
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | — | 321 | 138 | 172 |
| Cash Conversion Cycle | — | 321 | 138 | 172 |
| Working Capital Days | — | 100 | -24 | 91 |
| ROCE % | — | 19% | 52% | 14% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Gujarat Kidney & Super Speciality insights
50 extracted metrics + investor summaries across FY23–FY27.
Documents
Frequently Asked Questions about Gujarat Kidney & Super Speciality
What does Gujarat Kidney & Super Speciality Ltd do?
Where is Gujarat Kidney & Super Speciality Ltd (GKSL) listed?
Which sector does Gujarat Kidney & Super Speciality Ltd belong to?
What is the market capitalisation of Gujarat Kidney & Super Speciality Ltd?
What is the PE ratio of Gujarat Kidney & Super Speciality Ltd?
What is the 52-week high and low of Gujarat Kidney & Super Speciality Ltd?
What is the Return on Equity (ROE) of Gujarat Kidney & Super Speciality Ltd?
Company Information
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GKSL.md for Gujarat Kidney & Super Speciality Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.